COLLEEN BOYD: Open Payments
NPI 1740524768 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,063 in 300 payments from 40 companies in 2025. Trend: 2023 $5,632 · 2024 $5,722 · 2025 $6,063
Food & beverage: $6,063
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 33 | $920 |
| ABBVIE INC. | 39 | $530 |
| UCB, Inc. | 22 | $428 |
| TG Therapeutics, Inc. | 20 | $424 |
| Novartis Pharmaceuticals Corporation | 22 | $403 |
| EMD Serono, Inc. | 9 | $300 |
| Lundbeck LLC | 15 | $267 |
| Teva Pharmaceuticals USA, Inc. | 18 | $211 |
| Eisai Inc. | 7 | $200 |
| Axsome Therapeutics, Inc. | 11 | $173 |
Products named: NUPLAZID, BRIUMVI, KESIMPTA, Leqembi, VYALEV, AUSTEDO XR, VYEPTI, Rystiggo.
Industry payments across SC — which companies pay providers there.
